Data shows potential of imatinib in pulmonary artery disease treatment
Saturday, October 11, 2008 10:00 IST Basel
An early proof-of-concept study presented shows promising results for imatinib in the treatment of pulmonary arterial hypertension (PAH), a severe, incurable blood vessel disorder.
